InsiderTrades.com logo

AXSM Insider Trading

Insider Ownership Percentage: 22.40%
Insider Buying (Last 12 Months): $200,466.00
Insider Selling (Last 12 Months): $112,258,645.08

Axsome Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Axsome Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Axsome Therapeutics Share Price & Price History

Current Price: $187.35
Price Change: ▲ Price Increase of +1.47 (0.79%)
As of 02/3/2026 05:00 PM ET

This chart shows the closing price history over time for AXSM up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Axsome Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/2/2026Herriot TabuteauCEOSell32,410$185.60$6,015,296.007,229View SEC Filing Icon  
1/22/2026Nick PizzieCFOSell12,000$187.92$2,255,040.0042,588View SEC Filing Icon  
1/21/2026Ari MaizelInsiderSell7,500$184.44$1,383,300.00View SEC Filing Icon  
1/7/2026Herriot TabuteauCEOSell31,261$170.38$5,326,249.187,229View SEC Filing Icon  
1/6/2026Herriot TabuteauCEOSell29,450$172.33$5,075,118.507,229View SEC Filing Icon  
1/5/2026Herriot TabuteauCEOSell78,703$171.28$13,480,249.847,229View SEC Filing Icon  
12/31/2025Mark E. SaadDirectorSell37,577$165.18$6,206,968.8610,002View SEC Filing Icon  
12/4/2025Herriot TabuteauCEOSell10,558$148.18$1,564,484.447,229View SEC Filing Icon  
12/3/2025Herriot TabuteauCEOSell20,163$146.94$2,962,751.227,229View SEC Filing Icon  
12/2/2025Herriot TabuteauCEOSell49,252$144.59$7,121,346.687,229View SEC Filing Icon  
11/5/2025Herriot TabuteauCEOSell21,775$134.49$2,928,519.757,229View SEC Filing Icon  
11/4/2025Herriot TabuteauCEOSell50,459$133.79$6,750,909.617,229View SEC Filing Icon  
11/3/2025Herriot TabuteauCEOSell91,705$132.34$12,136,239.707,229View SEC Filing Icon  
10/8/2025Herriot TabuteauCEOSell12,774$118.84$1,518,062.167,229View SEC Filing Icon  
10/7/2025Herriot TabuteauCEOSell13,390$118.77$1,590,330.307,229View SEC Filing Icon  
10/6/2025Herriot TabuteauCEOSell19,220$120.17$2,309,667.407,229View SEC Filing Icon  
9/22/2025Mark L. JacobsonCOOSell10,000$115.96$1,159,600.00View SEC Filing Icon  
9/16/2025Herriot TabuteauCEOSell19,719$114.19$2,251,712.617,229View SEC Filing Icon  
9/16/2025Mark L. JacobsonCOOSell45,783$114.48$5,241,237.84View SEC Filing Icon  
9/15/2025Herriot TabuteauCEOSell15,254$117.37$1,790,361.987,229View SEC Filing Icon  
9/12/2025Herriot TabuteauCEOSell27,907$118.96$3,319,816.727,229View SEC Filing Icon  
9/8/2025Mark ColemanDirectorBuy1,575$127.28$200,466.0048,212View SEC Filing Icon  
9/5/2025Mark E. SaadDirectorSell9,127$125.07$1,141,513.8910,002View SEC Filing Icon  
9/2/2025Roger JeffsDirectorSell13,464$123.68$1,665,227.5257,510View SEC Filing Icon  
8/28/2025Roger JeffsDirectorSell20,000$121.60$2,432,000.0090,974View SEC Filing Icon  
8/26/2025Roger JeffsDirectorSell20,000$120.03$2,400,600.00110,974View SEC Filing Icon  
8/22/2025Roger JeffsDirectorSell16,694$120.08$2,004,615.52150,974View SEC Filing Icon  
6/23/2025Hunter R. MurdockGeneral CounselSell6,014$100.12$602,121.68View SEC Filing Icon  
6/20/2025Hunter R. MurdockGeneral CounselSell7,500$102.47$768,525.00View SEC Filing Icon  
6/17/2025Hunter R. MurdockGeneral CounselSell7,500$100.26$751,950.00View SEC Filing Icon  
6/9/2025Mark L. JacobsonCOOSell25,000$110.44$2,761,000.005,783View SEC Filing Icon  
5/28/2025Mark L. JacobsonCOOSell20,000$103.45$2,069,000.005,783View SEC Filing Icon  
5/27/2025Mark ColemanDirectorSell3,750$105.47$395,512.5050,387View SEC Filing Icon  
5/27/2025Mark L. JacobsonCOOSell20,673$104.66$2,163,636.185,783View SEC Filing Icon  
5/20/2025Mark ColemanDirectorSell3,000$107.49$322,470.0054,137View SEC Filing Icon  
2/14/2025Nick PizzieCFOSell3,000$131.07$393,210.0042,187View SEC Filing Icon  
9/11/2024Mark E. SaadDirectorSell11,016$91.31$1,005,870.9610,002View SEC Filing Icon  
8/9/2024Mark L. JacobsonCOOSell47,739$84.26$4,022,488.145,783View SEC Filing Icon  
5/29/2024Mark L. JacobsonCOOSell7,910$74.31$587,792.105,783View SEC Filing Icon  
5/28/2024Mark ColemanDirectorSell5,249$75.21$394,777.2919,848View SEC Filing Icon  
4/1/2024Mark L. JacobsonCOOSell24,662$77.24$1,904,892.88View SEC Filing Icon  
3/14/2024Roger JeffsDirectorSell29,976$69.70$2,089,327.20120,756View SEC Filing Icon  
9/15/2023Mark ColemanDirectorSell11,016$75.19$828,293.0425,097View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Axsome Therapeutics (NASDAQ:AXSM)

81.49% of Axsome Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at AXSM by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Axsome Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/3/2026F m Investments LLC41,132$7.51M0.3%+4.1%0.082%Search for SEC Filing on Google Icon
2/3/2026Wesbanco Bank Inc.8,800$1.61M0.0%-33.8%0.017%Search for SEC Filing on Google Icon
2/3/2026GRIMES & Co WEALTH MANAGEMENT LLC1,460$0.27M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/3/2026Praxis Investment Management Inc.1,150$0.21M0.0%N/A0.002%Search for SEC Filing on Google Icon
2/3/2026Privium Fund Management B.V.56,878$10.39M1.9%+7.9%0.113%Search for SEC Filing on Google Icon
2/2/2026Principal Financial Group Inc.363,114$66.32M0.0%-1.4%0.720%Search for SEC Filing on Google Icon
2/2/2026Truist Financial Corp3,055$0.56M0.0%+56.3%0.006%Search for SEC Filing on Google Icon
2/2/2026Strs Ohio10,800$1.97M0.0%-9.2%0.021%Search for SEC Filing on Google Icon
2/2/2026Fifth Third Bancorp2,477$0.45M0.0%+1,068.4%0.005%Search for SEC Filing on Google Icon
2/2/2026Oppenheimer & Co. Inc.7,076$1.29M0.0%N/A0.014%Search for SEC Filing on Google Icon
1/30/2026State of New Jersey Common Pension Fund D11,923$2.18M0.0%-34.3%0.024%Search for SEC Filing on Google Icon
1/30/2026US Bancorp DE130,985$23.92M0.0%-0.4%0.260%Search for SEC Filing on Google Icon
1/30/2026Moody Aldrich Partners LLC40,273$7.36M1.4%-21.8%0.080%Search for SEC Filing on Google Icon
1/30/2026Values First Advisors Inc.4,402$0.80M0.4%-9.8%0.009%Search for SEC Filing on Google Icon
1/30/2026M&T Bank Corp2,560$0.47M0.0%+37.3%0.005%Search for SEC Filing on Google Icon
1/29/2026Comerica Bank12,683$2.32M0.0%-0.6%0.025%Search for SEC Filing on Google Icon
1/29/2026Pictet Asset Management Holding SA436,063$79.64M0.1%+20.4%0.865%Search for SEC Filing on Google Icon
1/29/2026UBS Group AG355,318$64.90M0.0%+67.2%0.705%Search for SEC Filing on Google Icon
1/29/2026Vanguard Group Inc.4,164,818$760.66M0.0%-0.4%8.262%Search for SEC Filing on Google Icon
1/29/2026Concurrent Investment Advisors LLC1,643$0.30M0.0%N/A0.003%Search for SEC Filing on Google Icon
1/29/2026China Universal Asset Management Co. Ltd.8,215$1.50M0.1%-6.1%0.016%Search for SEC Filing on Google Icon
1/29/2026NBC Securities Inc.2,435$0.45M0.0%-8.8%0.005%Search for SEC Filing on Google Icon
1/28/2026Arizona State Retirement System9,787$1.79M0.0%-4.0%0.019%Search for SEC Filing on Google Icon
1/28/2026Torray Investment Partners LLC14,794$2.70M0.4%-15.1%0.029%Search for SEC Filing on Google Icon
1/28/2026Peregrine Capital Management LLC46,633$8.52M0.3%-27.7%0.093%Search for SEC Filing on Google Icon
1/28/2026HB Wealth Management LLC34,102$6.23M0.0%+136.7%0.068%Search for SEC Filing on Google Icon
1/28/2026M&T Bank Corp49,466$8.28M0.0%+2,553.8%0.098%Search for SEC Filing on Google Icon
1/28/2026Universal Beteiligungs und Servicegesellschaft mbH68,858$12.58M0.0%+1.4%0.137%Search for SEC Filing on Google Icon
1/27/2026Zurcher Kantonalbank Zurich Cantonalbank 7,464$1.36M0.0%+6.8%0.015%Search for SEC Filing on Google Icon
1/27/2026Bayforest Capital Ltd478$87K0.1%-55.0%0.001%Search for SEC Filing on Google Icon
1/27/2026First Horizon Corp601$0.11M0.0%+117.8%0.001%Search for SEC Filing on Google Icon
1/27/2026GF Fund Management CO. LTD.990$0.18M0.0%-7.8%0.002%Search for SEC Filing on Google Icon
1/26/2026Mirae Asset Global Investments Co. Ltd.2,450$0.45M0.0%+27.0%0.005%Search for SEC Filing on Google Icon
1/23/2026Farther Finance Advisors LLC274$50K0.0%+602.6%0.001%Search for SEC Filing on Google Icon
1/23/2026Oak Ridge Investments LLC11,741$2.14M0.1%-2.7%0.023%Search for SEC Filing on Google Icon
1/23/2026Assetmark Inc.1,103$0.20M0.0%-12.0%0.002%Search for SEC Filing on Google Icon
1/23/2026Old North State Wealth Management LLC2,800$0.51M0.2%-18.8%0.006%Search for SEC Filing on Google Icon
1/23/2026Stanley Laman Group Ltd.17,918$3.27M0.4%+2.4%0.036%Search for SEC Filing on Google Icon
1/23/2026Iridian Asset Management LLC CT73,783$13.48M5.0%-11.7%0.146%Search for SEC Filing on Google Icon
1/23/2026Yorktown Management & Research Co Inc1,700$0.31M0.2%N/A0.003%Search for SEC Filing on Google Icon
1/23/2026Sumitomo Mitsui Trust Group Inc.1,900$0.35M0.0%N/A0.004%Search for SEC Filing on Google Icon
1/21/2026Franklin Street Advisors Inc. NC10,000$1.83M0.1%N/A0.020%Search for SEC Filing on Google Icon
1/20/2026Element Squared LLC8,079$1.48M0.8%N/A0.016%Search for SEC Filing on Google Icon
1/16/2026Aberdeen Group plc97,413$17.79M0.0%+2.9%0.193%Search for SEC Filing on Google Icon
1/15/2026Birch Financial Group LLC1,097$0.20M0.1%N/A0.002%Search for SEC Filing on Google Icon
1/15/2026J. Safra Sarasin Holding AG7,383$1.35M0.0%-17.0%0.015%Search for SEC Filing on Google Icon
1/14/2026Hennion & Walsh Asset Management Inc.38,386$7.01M0.2%-18.2%0.076%Search for SEC Filing on Google Icon
1/14/2026Pallas Capital Advisors LLC43,909$8.02M0.3%+11.3%0.087%Search for SEC Filing on Google Icon
1/12/2026DAVENPORT & Co LLC1,800$0.33M0.0%-3.6%0.004%Search for SEC Filing on Google Icon
1/9/2026SG Americas Securities LLC17,681$3.23M0.0%+46.2%0.035%Search for SEC Filing on Google Icon
1/9/2026Assenagon Asset Management S.A.467,982$85.47M0.1%+58.8%0.928%Search for SEC Filing on Google Icon
1/8/2026Wealth Enhancement Advisory Services LLC21,758$3.74M0.0%+1.2%0.043%Search for SEC Filing on Google Icon
1/5/2026GAMMA Investing LLC268$49K0.0%+65.4%0.001%Search for SEC Filing on Google Icon
1/1/2026JPMorgan Chase & Co.250,513$30.43M0.0%+42.6%0.497%Search for SEC Filing on Google Icon
12/2/2025Allworth Financial LP1,442$0.18M0.0%+6.6%0.003%Search for SEC Filing on Google Icon
12/2/2025IFP Advisors Inc63,284$7.69M0.2%-1.1%0.126%Search for SEC Filing on Google Icon
11/24/2025CIBC Private Wealth Group LLC14,375$1.75M0.0%+5.0%0.029%Search for SEC Filing on Google Icon
11/21/2025CIBC Bancorp USA Inc.4,314$0.52M0.0%N/A0.009%Search for SEC Filing on Google Icon
11/20/2025Wilmington Savings Fund Society FSB716$87K0.0%+4,375.0%0.001%Search for SEC Filing on Google Icon
11/18/2025Advisory Services Network LLC330$40K0.0%N/A0.001%Search for SEC Filing on Google Icon
11/17/2025Castleark Management LLC15,143$1.84M0.1%-60.2%0.030%Search for SEC Filing on Google Icon
11/17/2025CANADA LIFE ASSURANCE Co8,991$1.06M0.0%+21.4%0.018%Search for SEC Filing on Google Icon
11/17/2025Woodline Partners LP331,864$40.31M0.2%+0.2%0.658%Search for SEC Filing on Google Icon
11/17/2025Dark Forest Capital Management LP7,267$0.88M0.0%-57.0%0.014%Search for SEC Filing on Google Icon
11/17/2025Voleon Capital Management LP16,734$2.03M0.0%N/A0.033%Search for SEC Filing on Google Icon
11/17/2025Verition Fund Management LLC1,989$0.24M0.0%N/A0.004%Search for SEC Filing on Google Icon
11/17/2025Vestal Point Capital LP150,000$18.22M0.8%N/A0.298%Search for SEC Filing on Google Icon
11/17/2025Quarry LP1,250$0.15M0.0%-50.0%0.002%Search for SEC Filing on Google Icon
11/17/2025Qube Research & Technologies Ltd325,626$39.55M0.0%-16.9%0.646%Search for SEC Filing on Google Icon
11/17/2025Northern Trust Corp409,535$49.74M0.0%+0.0%0.812%Search for SEC Filing on Google Icon
11/17/2025Mariner LLC16,617$2.02M0.0%+6.6%0.033%Search for SEC Filing on Google Icon
11/17/2025Mercer Global Advisors Inc. ADV1,962$0.24M0.0%N/A0.004%Search for SEC Filing on Google Icon
11/17/2025Millennium Management LLC5,741$0.70M0.0%-81.3%0.011%Search for SEC Filing on Google Icon
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.18,802$2.28M0.0%-15.2%0.037%Search for SEC Filing on Google Icon
11/17/2025Jain Global LLC9,007$1.09M0.0%N/A0.018%Search for SEC Filing on Google Icon
11/17/2025HighVista Strategies LLC9,348$1.14M0.3%-14.3%0.019%Search for SEC Filing on Google Icon
11/17/2025Eventide Asset Management LLC746,398$90.64M1.5%+2.9%1.481%Search for SEC Filing on Google Icon
11/17/2025Brevan Howard Capital Management LP7,334$0.89M0.0%-50.4%0.015%Search for SEC Filing on Google Icon
11/17/2025Bank of America Corp DE361,261$43.88M0.0%-52.1%0.717%Search for SEC Filing on Google Icon
11/17/2025Aquatic Capital Management LLC7,426$0.90M0.0%-68.6%0.015%Search for SEC Filing on Google Icon
11/17/2025Algert Global LLC44,150$5.36M0.1%+18.0%0.088%Search for SEC Filing on Google Icon
11/17/2025Alliancebernstein L.P.63,065$7.66M0.0%+37.2%0.125%Search for SEC Filing on Google Icon
11/17/2025Ameriprise Financial Inc.108,236$13.15M0.0%+54.4%0.215%Search for SEC Filing on Google Icon
11/14/2025Creative Planning21,278$2.58M0.0%+32.3%0.042%Search for SEC Filing on Google Icon
11/14/2025Lazard Asset Management LLC21,837$2.65M0.0%-25.5%0.043%Search for SEC Filing on Google Icon
11/14/2025SummitTX Capital L.P.15,350$1.86M0.1%+466.6%0.030%Search for SEC Filing on Google Icon
11/14/2025Raymond James Financial Inc.158,689$19.27M0.0%-1.7%0.315%Search for SEC Filing on Google Icon
11/14/2025Bellevue Group AG52,335$6.36M0.1%-7.0%0.104%Search for SEC Filing on Google Icon
11/14/2025Deep Track Capital LP900,000$109.31M3.1%+12.3%1.785%Search for SEC Filing on Google Icon
11/14/2025Freestone Grove Partners LP2,494$0.30M0.0%N/A0.005%Search for SEC Filing on Google Icon
11/14/2025Man Group plc287,908$34.97M0.1%-45.2%0.571%Search for SEC Filing on Google Icon
11/14/2025Orbimed Advisors LLC531,800$64.59M1.6%+24.3%1.055%Search for SEC Filing on Google Icon
11/14/2025Zurcher Kantonalbank Zurich Cantonalbank 6,989$0.85M0.0%+8.4%0.014%Search for SEC Filing on Google Icon
11/14/2025UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC86,691$10.53M0.0%-35.4%0.172%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP8,207$1M0.0%N/A0.016%Search for SEC Filing on Google Icon
11/14/2025Wellington Management Group LLP1,334,560$162.08M0.0%+84.1%2.647%Search for SEC Filing on Google Icon
11/14/2025Comerica Bank12,758$1.55M0.0%+275.7%0.025%Search for SEC Filing on Google Icon
11/14/2025Perbak Capital Partners LLP6,313$0.77M0.1%+33.5%0.013%Search for SEC Filing on Google Icon
11/14/2025F m Investments LLC39,495$4.80M0.2%+22.6%0.078%Search for SEC Filing on Google Icon
11/14/2025Glenmede Investment Management LP7,232$0.88M0.0%-12.7%0.014%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Axsome Therapeutics logo
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl-D-aspartate receptor antagonist with multimodal activity indicated for the treatment of major depressive disorder; and Sunosi (solriamfetol), a medication indicated to the treatment of excessive daytime sleepiness in patients with narcolepsy or obstructive sleep apnea. It is also developing AXS-05, which is in Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation; AXS-07, an investigational medicine that has completed Phase III trials for the acute treatment of migraine; AXS-12, an investigational medicine, which is in Phase III trial to treat narcolepsy; AXS-14, a selective and potent norepinephrine reuptake inhibitor that has completed Phase III trial for the treatment of fibromyalgia and other conditions; and solriamfetol, a dual-acting dopamine and norepinephrine reuptake inhibitor, which has completed a Phase 2 trial for treating attention-deficit/hyperactivity disorder, and is in phase 2 major depressive, binge eating, and shift work disorder. Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.
Read More on Axsome Therapeutics

Today's Range

Now: $187.35
Low: $185.73
High: $190.76

50 Day Range

MA: $164.72
Low: $142.09
High: $189.10

52 Week Range

Now: $187.35
Low: $86.99
High: $191.50

Volume

904,069 shs

Average Volume

671,933 shs

Market Capitalization

$9.44 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.4

Who are the company insiders with the largest holdings of Axsome Therapeutics?

Axsome Therapeutics' top insider investors include:
  1. Roger Jeffs (Director)
  2. Mark Coleman (Director)
  3. Nick Pizzie (CFO)
  4. Mark E Saad (Director)
  5. Herriot Tabuteau (CEO)
  6. Mark L Jacobson (COO)
  7. Ari Maizel (Insider)
  8. Hunter R Murdock (General Counsel)
  9. Mark L Jacobson (COO)
Learn More about top insider investors at Axsome Therapeutics.

Who are the major institutional investors of Axsome Therapeutics?

Axsome Therapeutics' top institutional shareholders include:
  1. Vanguard Group Inc. — 8.26%
  2. Assenagon Asset Management S.A. — 0.93%
  3. Pictet Asset Management Holding SA — 0.87%
  4. Principal Financial Group Inc. — 0.72%
  5. UBS Group AG — 0.70%
  6. US Bancorp DE — 0.26%
Learn More about top institutional investors of Axsome Therapeutics stock.

Which institutional investors are selling Axsome Therapeutics stock?

During the last quarter, AXSM stock was sold by these institutional investors:
  1. Peregrine Capital Management LLC
  2. Vanguard Group Inc.
  3. Moody Aldrich Partners LLC
  4. Iridian Asset Management LLC CT
  5. Hennion & Walsh Asset Management Inc.
  6. State of New Jersey Common Pension Fund D
  7. Principal Financial Group Inc.
  8. Torray Investment Partners LLC
During the last year, company insiders that have sold Axsome Therapeutics company stock include:
  1. Roger Jeffs (Director)
  2. Mark Coleman (Director)
  3. Nick Pizzie (CFO)
  4. Mark E Saad (Director)
  5. Herriot Tabuteau (CEO)
  6. Mark L Jacobson (COO)
  7. Ari Maizel (Insider)
  8. Hunter R Murdock (General Counsel)
Learn More investors selling Axsome Therapeutics stock.

Which institutional investors are buying Axsome Therapeutics stock?

Within the previous quarter, AXSM stock was bought by institutional investors including:
  1. Assenagon Asset Management S.A.
  2. UBS Group AG
  3. Pictet Asset Management Holding SA
  4. M&T Bank Corp
  5. HB Wealth Management LLC
  6. Franklin Street Advisors Inc. NC
  7. Element Squared LLC
  8. Oppenheimer & Co. Inc.